Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to β sheet in tau protein linked to Alzheimer’s disease

Alberto Cornejo, Felipe Aguilar Sandoval, Leonardo Caballero, Luis Machuca, Patricio Muñoz, Julio Caballero, George Perry, Alejandro Ardiles, Carlos Areche, Francisco Melo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Alzheimer’s disease is a common tauopathy where fibril formation and aggregates are the hallmark of the disease. Efforts targeting amyloid-β plaques have succeeded to remove plaques but failed in clinical trials to improve cognition; thus, the current therapeutic strategy is at preventing tau aggregation. Here, we demonstrated that four phenolic diterpenoids and rosmarinic acid inhibit fibrillization. Since, rosmarinic acid was the most active compound, we observe morphological changes in atomic force microscopy images after treatment. Hence, rosmarinic acid leads to a decrease in amide regions I and III, indicating that rosmarinic acid prevents β-sheet assembly. Molecular docking study inside the steric zipper model of the hexapeptide 306VQIVYK311 involved in fibrillization and β sheet formation, suggests that rosmarinic acid binds to the steric zipper with similar chemical interactions with respect to those observed for orange G, a known pharmacofore for amyloid.

Original languageEnglish
Pages (from-to)945-953
Number of pages9
JournalJournal of Enzyme Inhibition and Medicinal Chemistry
Volume32
Issue number1
DOIs
Publication statusPublished - 1 Jan 2017

Fingerprint

tau Proteins
Alzheimer Disease
Tauopathies
Diterpenes
Atomic Force Microscopy
Amyloid Plaques
Amyloid
Amides
Cognition
rosmarinic acid
Clinical Trials

Keywords

  • aggregation
  • Alzheimer’s disease
  • inhibition
  • pharmacophore
  • tau
  • β-sheet

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Medicine(all)

Cite this

Cornejo, Alberto ; Aguilar Sandoval, Felipe ; Caballero, Leonardo ; Machuca, Luis ; Muñoz, Patricio ; Caballero, Julio ; Perry, George ; Ardiles, Alejandro ; Areche, Carlos ; Melo, Francisco. / Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to β sheet in tau protein linked to Alzheimer’s disease. In: Journal of Enzyme Inhibition and Medicinal Chemistry. 2017 ; Vol. 32, No. 1. pp. 945-953.
@article{97bb84f603664daab624a57249969dda,
title = "Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to β sheet in tau protein linked to Alzheimer’s disease",
abstract = "Alzheimer’s disease is a common tauopathy where fibril formation and aggregates are the hallmark of the disease. Efforts targeting amyloid-β plaques have succeeded to remove plaques but failed in clinical trials to improve cognition; thus, the current therapeutic strategy is at preventing tau aggregation. Here, we demonstrated that four phenolic diterpenoids and rosmarinic acid inhibit fibrillization. Since, rosmarinic acid was the most active compound, we observe morphological changes in atomic force microscopy images after treatment. Hence, rosmarinic acid leads to a decrease in amide regions I and III, indicating that rosmarinic acid prevents β-sheet assembly. Molecular docking study inside the steric zipper model of the hexapeptide 306VQIVYK311 involved in fibrillization and β sheet formation, suggests that rosmarinic acid binds to the steric zipper with similar chemical interactions with respect to those observed for orange G, a known pharmacofore for amyloid.",
keywords = "aggregation, Alzheimer’s disease, inhibition, pharmacophore, tau, β-sheet",
author = "Alberto Cornejo and {Aguilar Sandoval}, Felipe and Leonardo Caballero and Luis Machuca and Patricio Mu{\~n}oz and Julio Caballero and George Perry and Alejandro Ardiles and Carlos Areche and Francisco Melo",
year = "2017",
month = "1",
day = "1",
doi = "10.1080/14756366.2017.1347783",
language = "English",
volume = "32",
pages = "945--953",
journal = "Journal of Enzyme Inhibition and Medicinal Chemistry",
issn = "1475-6366",
publisher = "Informa Healthcare",
number = "1",

}

Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to β sheet in tau protein linked to Alzheimer’s disease. / Cornejo, Alberto; Aguilar Sandoval, Felipe; Caballero, Leonardo; Machuca, Luis; Muñoz, Patricio; Caballero, Julio; Perry, George; Ardiles, Alejandro; Areche, Carlos; Melo, Francisco.

In: Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 32, No. 1, 01.01.2017, p. 945-953.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to β sheet in tau protein linked to Alzheimer’s disease

AU - Cornejo, Alberto

AU - Aguilar Sandoval, Felipe

AU - Caballero, Leonardo

AU - Machuca, Luis

AU - Muñoz, Patricio

AU - Caballero, Julio

AU - Perry, George

AU - Ardiles, Alejandro

AU - Areche, Carlos

AU - Melo, Francisco

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Alzheimer’s disease is a common tauopathy where fibril formation and aggregates are the hallmark of the disease. Efforts targeting amyloid-β plaques have succeeded to remove plaques but failed in clinical trials to improve cognition; thus, the current therapeutic strategy is at preventing tau aggregation. Here, we demonstrated that four phenolic diterpenoids and rosmarinic acid inhibit fibrillization. Since, rosmarinic acid was the most active compound, we observe morphological changes in atomic force microscopy images after treatment. Hence, rosmarinic acid leads to a decrease in amide regions I and III, indicating that rosmarinic acid prevents β-sheet assembly. Molecular docking study inside the steric zipper model of the hexapeptide 306VQIVYK311 involved in fibrillization and β sheet formation, suggests that rosmarinic acid binds to the steric zipper with similar chemical interactions with respect to those observed for orange G, a known pharmacofore for amyloid.

AB - Alzheimer’s disease is a common tauopathy where fibril formation and aggregates are the hallmark of the disease. Efforts targeting amyloid-β plaques have succeeded to remove plaques but failed in clinical trials to improve cognition; thus, the current therapeutic strategy is at preventing tau aggregation. Here, we demonstrated that four phenolic diterpenoids and rosmarinic acid inhibit fibrillization. Since, rosmarinic acid was the most active compound, we observe morphological changes in atomic force microscopy images after treatment. Hence, rosmarinic acid leads to a decrease in amide regions I and III, indicating that rosmarinic acid prevents β-sheet assembly. Molecular docking study inside the steric zipper model of the hexapeptide 306VQIVYK311 involved in fibrillization and β sheet formation, suggests that rosmarinic acid binds to the steric zipper with similar chemical interactions with respect to those observed for orange G, a known pharmacofore for amyloid.

KW - aggregation

KW - Alzheimer’s disease

KW - inhibition

KW - pharmacophore

KW - tau

KW - β-sheet

UR - http://www.scopus.com/inward/record.url?scp=85023778282&partnerID=8YFLogxK

U2 - 10.1080/14756366.2017.1347783

DO - 10.1080/14756366.2017.1347783

M3 - Article

VL - 32

SP - 945

EP - 953

JO - Journal of Enzyme Inhibition and Medicinal Chemistry

JF - Journal of Enzyme Inhibition and Medicinal Chemistry

SN - 1475-6366

IS - 1

ER -